Jørgen Georgsen

Medical director

19962019
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Jørgen Georgsen is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 13 Similar Profiles
Denmark Medicine & Life Sciences
Hepatitis B Medicine & Life Sciences
Hepatitis B virus Medicine & Life Sciences
Virus Diseases Medicine & Life Sciences
Drug Users Medicine & Life Sciences
Hepatitis E Medicine & Life Sciences
Hepatitis C Medicine & Life Sciences
Hepacivirus Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1996 2019

Post-transfusion hemoglobin values and patient blood management

Moerman, J., Vermeulen, E., Van Mullem, M., Badts, A. M., Lybeert, P., Compernolle, V. & Georgsen, J., Jun 2019, In : Acta Clinica Belgica. 74, 3, p. 164-168

Research output: Contribution to journalJournal articleResearchpeer-review

Retrospective Studies
Communication
Physicians
Self-Assessment

Patient blood management knowledge and practice among clinicians from seven European university hospitals: A multicentre survey

Manzini, P. M., Dall'Omo, A. M., D'Antico, S., Valfrè, A., Pendry, K., Wikman, A., Fischer, D., Borg-Aquilina, D., Laspina, S., van Pampus, E. C. M., van Kraaij, M., Bruun, M. T., Georgsen, J., Grant-Casey, J., Babra, P. S., Murphy, M. F., Folléa, G. & Aranko, K., Jan 2018, In : Vox Sanguinis. 113, 1, p. 60–71

Research output: Contribution to journalJournal articleResearchpeer-review

Knowledge Management
Practice Management
Erythrocyte Transfusion
Surveys and Questionnaires

An assessment of differences in costs and health benefits of serology and NAT screening of donations for blood transfusion in different Western countries

ABO RBDM Health Economics and Outcomes Working Group & Collaborators & Titlestad, K., 29. Aug 2017, In : Vox Sanguinis. 112, 6, p. 518-525

Research output: Contribution to journalJournal articleResearchpeer-review

Insurance Benefits
Serology
Cost-Benefit Analysis
Quality-Adjusted Life Years
HIV

Danish Decision to Discontinue NAT Screening: Residual Risk Estimates for Transfusion Transmitted Viral Infections with and without NAT

Baudewijn, L. & Georgsen, J., 2017. 1 p.

Research output: Contribution to conference without publisher/journalConference abstract for conferenceResearchpeer-review

Activities 1995 2017

Foredrag: "From Whole Blood to Plasmapheresis: Errors Made & Lessons Learnt"

Jørgen Georgsen (Lecturer), Kjell Titlestad (Lecturer)
7. Nov 20178. Nov 2017

Activity: Talks and presentationsTalks and presentations in private or public companies

70th Annual Meeting of the American Association of Blood Banks, San Diegoo, California

Jørgen Georgsen (Participant)
7. Oct 201710. Oct 2017

Activity: Attending an eventOrganisation or participation in workshops, courses or seminars

Foredrag: "Should Denmark discontinue NAT? Residual Risk Estimates for transfusion transmitted HIV, HBV amd HCV with or without NAT.

Leen Baudewijn (Lecturer), Jørgen Georgsen (Lecturer)
7. Oct 201710. Oct 2017

Activity: Talks and presentationsTalks and presentations in private or public companies

Foredrag: "Where and how to collect blood in a changing world"

Jørgen Georgsen (Lecturer)
17. Jun 201721. Jun 2017

Activity: Talks and presentationsTalks and presentations in private or public companies

27th Regional Congress of the International Society of Blood Transfusion

Jørgen Georgsen (Participant)
7. Jun 201710. Jun 2017

Activity: Attending an eventConference organisation or participation